Solesence, Inc. Common Stock
Solesence, Inc. Common Stock Fundamental Analysis
Solesence, Inc. Common Stock (SLSN) shows weak financial fundamentals with a PE ratio of 75.84, profit margin of 1.72%, and ROE of 6.53%. The company generates $0.1B in annual revenue with strong year-over-year growth of 40.35%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 42.1/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze SLSN's fundamental strength across five key dimensions:
Efficiency Score
WeakSLSN struggles to generate sufficient returns from assets.
Valuation Score
ModerateSLSN shows balanced valuation metrics.
Growth Score
ModerateSLSN shows steady but slowing expansion.
Financial Health Score
ModerateSLSN shows balanced financial health with some risks.
Profitability Score
WeakSLSN struggles to sustain strong margins.
Key Financial Metrics
Is SLSN Expensive or Cheap?
P/E Ratio
SLSN trades at 75.84 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, SLSN's PEG of -0.98 indicates potential undervaluation.
Price to Book
The market values Solesence, Inc. Common Stock at 4.71 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 17.08 times EBITDA. This signals the market has high growth expectations.
How Well Does SLSN Make Money?
Net Profit Margin
For every $100 in sales, Solesence, Inc. Common Stock keeps $1.72 as profit after all expenses.
Operating Margin
Core operations generate 1.87 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $6.53 in profit for every $100 of shareholder equity.
ROA
Solesence, Inc. Common Stock generates $1.98 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Solesence, Inc. Common Stock generates limited operating cash flow of $-8.20M, signaling weaker underlying cash strength.
Free Cash Flow
Solesence, Inc. Common Stock generates weak or negative free cash flow of $-11.21M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.16 in free cash annually.
FCF Yield
SLSN converts -13.47% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
75.84
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.98
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.71
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.31
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.46
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.84
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.07
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.03
vs 25 benchmark
How SLSN Stacks Against Its Sector Peers
| Metric | SLSN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 75.84 | 23.01 | Worse (Expensive) |
| ROE | 6.53% | 1228.00% | Weak |
| Net Margin | 1.72% | -4010.00% (disorted) | Weak |
| Debt/Equity | 1.46 | 0.78 | Weak (High Leverage) |
| Current Ratio | 1.84 | 2.35 | Neutral |
| ROA | 1.98% | -157546.00% (disorted) | Weak |
SLSN outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Solesence, Inc. Common Stock's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
28.24%
Industry Style: Defensive, Dividend, Low Volatility
High GrowthEPS CAGR
31.81%
Industry Style: Defensive, Dividend, Low Volatility
High GrowthFCF CAGR
-38.68%
Industry Style: Defensive, Dividend, Low Volatility
Declining